Cellectar Biosciences Inc (CLRB)
3.295
-0.04
(-1.05%)
USD |
NASDAQ |
May 17, 16:00
3.295
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
September 30, 2009 | 0.00 |
June 30, 2009 | 0.00 |
March 31, 2009 | 0.00 |
December 31, 2008 | 0.00 |
September 30, 2008 | 0.00 |
June 30, 2008 | 0.00 |
March 31, 2008 | 0.00 |
December 31, 2007 | 0.00 |
Date | Value |
---|---|
September 30, 2007 | 0.00 |
June 30, 2007 | 0.00 |
March 31, 2007 | 0.00 |
December 31, 2006 | 0.00 |
September 30, 2006 | 0.00 |
June 30, 2006 | 0.00 |
March 31, 2006 | 0.00 |
December 31, 2005 | 0.00 |
September 30, 2005 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
Perspective Therapeutics Inc | 1.725M |
Eli Lilly and Co | 26.21B |
Actinium Pharmaceuticals Inc | -- |
Bristol-Myers Squibb Co | 55.68B |
Altimmune Inc | 0.00 |